Cadre Holdings, Inc. SEC filings document the company's safety-equipment business, public-company governance and NYSE-listed common stock. Form 8-K reports cover operating results, financial condition, Regulation FD presentations, material events and related exhibits for its law enforcement, first responder, military and nuclear safety markets.
Cadre's filings also include proxy materials for annual meeting matters, board and stockholder voting procedures, and corporate governance disclosures. Financial-result filings discuss GAAP measures alongside non-GAAP metrics such as EBITDA, adjusted EBITDA and adjusted EBITDA margin, while event reports address material agreements, acquisition-related communications, capital-structure disclosures and security registration details for CDRE common stock.
Cadre Holdings, Inc. reported that President Brad Williams received new equity awards tied to future stock performance. On June 16, 2026, he was granted stock options for 136,000 and 109,500 shares of common stock at an exercise price of $28.75 per share, expiring on June 16, 2033. He also received 82,000 and 57,500 restricted stock units. All four awards vest only if, on or before June 16, 2033, Cadre’s stock reaches a volume-weighted average price of at least $60 or $80 per share over 20 consecutive trading days, and then only after at least three years have passed from the grant date.
Cadre Holdings CEO and chairman Warren B. Kanders received significant performance-based equity awards in the form of stock options and restricted stock units. On the reported date, he was granted options to purchase 496,500 and 616,500 shares of common stock at an exercise price of $28.75 per share, and 261,000 and 373,000 restricted stock units.
All awards vest only if, on or before June 16, 2033, Cadre’s stock reaches specified volume-weighted average price targets of $60 or $80 per share over a 20-day period. These are compensation grants, not open-market share purchases or sales.
Cadre Holdings, Inc. director, CEO and chairman Warren B. Kanders reported that Kanders SAF, LLC, an entity he manages, sold a total of 225,000 shares of Cadre common stock in open-market transactions on June 15–17, 2026.
The LLC sold 100,000 shares at a weighted average price of $30.03 on June 15, 100,000 shares at $28.19 on June 16, and 25,000 shares at $28.68 on June 17, across multiple trades each day. After these sales, Kanders SAF, LLC held 9,692,039 shares of Cadre common stock.
The filing also lists other indirect holdings, including 1,305,650 shares held by a Roth IRA for Warren B. Kanders and 23,450 shares held by a Roth IRA for his spouse, plus 22,888 shares held directly. Kanders disclaims beneficial ownership of certain securities except to the extent of his pecuniary interest.
Warren B. Kanders reported sales of Common Stock under Rule 144. The filing lists two transactions: 100,000 shares sold on 03/20/2026 for $3,140,000 and 100,000 shares sold on 03/23/2026 for $3,193,000. The record also includes a liquidating distribution tied to Maui Holdings LLC dated 12/07/2021 for 15,866,703 shares as shown in the excerpt.
Cadre Holdings, Inc. reported results of its 2026 Annual Meeting of Stockholders held on May 29, 2026. The terms of directors Gianmaria C. Delzanno and Deborah A. DeCotis expired, and they were not nominated for re-election; the company states this was not due to any disagreement.
Stockholder participation was high, with 40,406,208 of 42,797,451 shares of Common Stock present or represented by proxy and entitled to vote, representing approximately 94.41% of shares entitled to vote. Shareholders elected five directors — Warren B. Kanders, William Quigley, Hamish Norton, Nicholas Sokolow, and Mary Kissel — and ratified KPMG LLP as independent registered public accounting firm for the year ending December 31, 2026.
Cadre Holdings, Inc. director Mary E. Kissel has filed an initial Form 3 reporting her beneficial ownership of the company’s common stock. The filing lists 0 shares of Common Stock, $0.0001 par value per share, held directly as of the reported date, and does not show any buy or sell transactions.
Cadre Holdings, Inc. director Nicolas Sokolow filed an initial Form 3 reporting his ownership of the company’s common stock. The filing shows indirect holdings of 69,231 shares through ST Investors Fund, LLC, 224,000 shares through Korsak Holdings, LLC, and 317,567 shares through Madetys Investments, LLC, plus 40,347 shares held directly.
The indirect positions are owned by the respective LLCs, and Sokolow disclaims beneficial ownership of those securities except to the extent of his pecuniary interest in them.
Cadre Holdings, Inc. filing an Amendment No. 1 to a Schedule 13G/A reports that Capital International Investors (CII) beneficially owns 1,260,806 shares of Common Stock, equal to 3.0% of the 42,726,564 shares believed outstanding as shown in the filing. The filing lists CII's sole voting and dispositive power over the 1,260,806 shares. The signature block shows the amendment was signed on 05/13/2026.
Cadre Holdings reported higher sales but sharply lower profit for the quarter ended March 31, 2026. Net sales rose to $155.4 million from $130.1 million, driven mainly by recent acquisitions, including TYR Tactical, which added new product lines and customers.
Despite this 19.5% sales increase, net income fell to $2.0 million from $9.2 million. Profit was pressured by higher manufacturing costs, inventory step-up amortization, increased compensation, transaction and related party expenses tied to acquisitions, and higher interest expense from additional debt. Adjusted EBITDA was relatively stable at $21.1 million versus $20.5 million.
Cadre used significant cash for acquisitions, reducing cash and cash equivalents to $41.3 million, while total debt rose to $365.8 million (gross). Orders backlog increased to $355.4 million, reflecting strong demand in explosive ordnance disposal, TYR products, nuclear safety solutions and duty gear.
Cadre Holdings reported mixed first quarter 2026 results. Net sales rose to $155.4 million, up 19% year-over-year, driven mainly by recent acquisitions, while gross profit increased modestly to $60.2 million. However, gross margin declined to 38.7% from 43.1% and net income fell sharply to $2.0 million from $9.2 million as higher compensation, interest, transaction and related party expenses weighed on earnings.
Adjusted EBITDA edged up to $21.1 million, with margin compressing to 13.6% from 15.8%. The company highlighted a record $355 million orders backlog, up $166 million since the start of the year, helped by the blast attenuation seat contract and the TYR acquisition. Cadre closed acquisitions of TYR Tactical and Alien Gear Holsters and reaffirmed 2026 guidance for net sales of $736–$758 million and adjusted EBITDA of $136–$141 million, while declaring a quarterly dividend of $0.10 per share.